As an expert in oncology and cardiology, Daiichi Sankyo is tackling the most common causes of death in Germany and Europe: strokes, heart attacks and cancer. Formed by a merger, the Japanese pharmaceutical company develops innovative drugs and therapeutic approaches. J-BIG spoke to Dr Martina Witzel, Head of Oncology Germany, and Benoit Creveau, General Manager for Daiichi … [Read more...] about Daiichi Sankyo“A company that is only interested in profit will not be successful”